Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
- Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)Active Not Recruiting
Sponsor: BeOne Medicines
CLL
United States, Australia, Austria, Brazil, Canada +16 more
Sponsor: Takeda
Short Bowel Syndrome
Japan
- Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial CancerActive Not Recruiting
Sponsor: AstraZeneca
Endometrial Neoplasms
United States, Australia, Belgium, Brazil, Canada +17 more
Sponsor: Takeda
Hereditary Angioedema (HAE)
Japan
Sponsor: Showa Inan General Hospital
LRG Levels
Japan
Sponsor: BeOne Medicines
Metastatic Gastric Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma
United States, Argentina, Austria, Brazil, China +11 more
Sponsor: Merck Sharp & Dohme LLC
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
United States, Australia, Belgium, Brazil, Canada +24 more
Sponsor: Merck Sharp & Dohme LLC
Cervical Cancer
United States, Argentina, Australia, Austria, Belgium +27 more
Sponsor: Eli Lilly and Company
Neoplasms · Child · Adolescent
United States, Australia, Belgium, France, Germany +5 more
- AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid TumorsRecruiting
Sponsor: Amgen
Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR)
United States, Australia, Belgium, Canada, China +5 more
Sponsor: Merck Sharp & Dohme LLC
Cervical Cancer
United States, Argentina, Austria, Belgium, Brazil +22 more
Sponsor: Takeda
Cytomegalovirus (CMV)
Japan
Sponsor: Takeda
Immune Thrombocytopenic Purpura (ITP)
United States, Australia, Bulgaria, China, Croatia +13 more
- Lefamulin Post-Market Surveillance StudyRecruiting
Sponsor: Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
Community-Acquired Pneumonia (CAP)
China
Sponsor: Novartis Pharmaceuticals
Atypical Hemolytic Uremic Syndrome
United States, Brazil, China, Czechia, India +3 more
Sponsor: Eli Lilly and Company
Ulcerative Colitis · Ulcerative Colitis Chronic · Inflammatory Bowel Diseases · Crohn's Disease
United States, Austria, Belgium, Brazil, Canada +11 more
Sponsor: Astellas Pharma Global Development, Inc.
Non-small Cell Lung Cancer (NSCLC)
United States, Japan
- A Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia ARecruiting
Sponsor: Takeda
Acquired Hemophilia A
Japan
- Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian CancerRecruiting
Sponsor: NRG Oncology
Fallopian Tube Endometrioid Adenocarcinoma · Fallopian Tube High Grade Serous Adenocarcinoma · Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor · FIGO Stage III Ovarian Cancer 2014
United States, Japan, Puerto Rico
Sponsor: Eli Lilly and Company
Carcinoma, Non-Small-Cell Lung
United States, Australia, Austria, Belgium, Brazil +24 more
- A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseActive Not Recruiting
Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Crohn Disease · Colitis, Ulcerative
United States, Austria, Bulgaria, Czechia, Georgia +11 more
Sponsor: Kagawa University
Out-of-hospital Cardiac Arrest (OHCA) · ECMO Treatment · Temperature · Post Cardiac Arrest Syndrome
Japan
- Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal HemoglobinuriaActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Paroxysmal Nocturnal Hemoglobinuria
United States, Brazil, China, Czechia, France +12 more
Sponsor: Takeda
Primary Immunodeficiency Diseases (PID)
Japan
Sponsor: Eli Lilly and Company
Breast Cancer
United States, Australia, Belgium, Canada, China +7 more